GeneDx Holdings Corp. (WGS) Q3 2026 earnings results
GeneDx Holdings Corp. (WGS) reported Q3 2026 results on Nov 9, 2026, 4:10:31 PM ET: GAAP EPS -$0.41 vs. $0.07 expected (miss by $0.48); revenue $123.10M vs. $122.92M expected (beat by 0.1%). Outlook: Full year 2026 revenue guidance is $475 to $490 million and fourth quarter 2026 revenue guidance is $135 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.41 | $0.07 | Miss by $0.48 |
| Revenue | $123.10M | $122.92M | Beat by 0.1% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 9, 2026, 4:10:31 PM ET. Nexqual published them 43 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 5.4% from $116.74M; GAAP diluted EPS was -$0.41 vs. -$0.27 (−51.9%).
Stock reaction
The results came out after the market closed. WGS is trading at $53.43 as of 11:40 AM ET on November 10, 2026, down 18.7% from its $65.72 close on November 9, 2026 before the results.
Questions and answers
Did GeneDx Holdings Corp. beat earnings expectations?
No. GeneDx Holdings Corp. reported GAAP EPS of -$0.41 against an average analyst estimate of $0.07 (miss by $0.48), and revenue of $123.10M against $122.92M expected (beat by 0.1%).
What were GeneDx Holdings Corp.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$0.41 and revenue of $123.10M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 5.4% from $116.74M; GAAP diluted EPS was -$0.41 vs. -$0.27 (−51.9%).
When did GeneDx Holdings Corp. report Q3 2026 earnings?
Nov 9, 2026, 4:10:31 PM ET, in an SEC 8-K filing (Item 2.02).
How did WGS stock react to the earnings?
The results came out after the market closed. WGS is trading at $53.43 as of 11:40 AM ET on November 10, 2026, down 18.7% from its $65.72 close on November 9, 2026 before the results.
What did GeneDx Holdings Corp. say about its outlook?
Full year 2026 revenue guidance is $475 to $490 million and fourth quarter 2026 revenue guidance is $135 million.
More on WGS
WGS stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 9, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:40 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:40 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt